Medicure (MCUJF) Liabilities from Discontinued Operations (2017)
Medicure (MCUJF) posted quarterly Liabilities from Discontinued Operations of 5491350.7 for Q4 2017, down 86.33% quarter-over-quarter from 40168076.37 in Q3 2017.
Medicure (MCUJF) Liabilities from Discontinued Operations (2017) Analysis & Trends
Medicure's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 5491350.7 for Q4 2017.
- In Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 5491350.7; the TTM figure through Dec 2017 stood at 5491350.7 (changed N/A YoY), while the FY2017 annual figure was 5377355.95, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2017 stood at 5491350.7, down from 40168076.37 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 40168076.37 in Q3 2017, with the low at 5491350.7 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 5.49 Mn |
| Dec 31, 2017 | 5.49 Mn |
| Sep 30, 2017 | 40.17 Mn |
| Sep 30, 2017 | 40.17 Mn |